Virtu Financial’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,306
| Closed | -$17K | – | 1372 |
|
|
2024
Q2 | $17K | Buy |
+3,306
| New | +$17K | ﹤0.01% | 1054 |
|
|
2024
Q1 | – | Sell |
-4,732
| Closed | -$19K | – | 1415 |
|
|
2023
Q4 | $19K | Buy |
+4,732
| New | +$19K | ﹤0.01% | 1326 |
|
|
2023
Q3 | – | Sell |
-726
| Closed | -$22K | – | 1312 |
|
|
2023
Q2 | $22K | Buy |
+726
| New | +$22K | ﹤0.01% | 1244 |
|
|
2022
Q3 | – | Sell |
-1,380
| Closed | -$57K | – | 1730 |
|
|
2022
Q2 | $57K | Buy |
+1,380
| New | +$57K | ﹤0.01% | 1089 |
|
|
2021
Q1 | – | Sell |
-1,632
| Closed | -$111K | – | 1601 |
|
|
2020
Q4 | $111K | Buy |
+1,632
| New | +$111K | 0.01% | 1030 |
|
|
2019
Q4 | – | Sell |
-867
| Closed | -$51K | – | 1440 |
|
|
2019
Q3 | $51K | Buy |
+867
| New | +$51K | ﹤0.01% | 1190 |
|
|
2017
Q4 | – | Sell |
-838
| Closed | -$52K | – | 2364 |
|
|
2017
Q3 | $52K | Buy |
+838
| New | +$52K | ﹤0.01% | 2220 |
|